|Mr. Thomas Warthoe||Co-Founder, CEO & Director||N/A||N/A||1967|
|Mr. Peter Warthoe||Co-Founder & Chief Scientific Officer||N/A||N/A||1967|
|Mr. Kasper Damgaard Boel Rousoe||Chief Financial Officer||N/A||N/A||N/A|
|Mr. Jakob Broberg Lind||Global Sales Director Clinical||N/A||N/A||N/A|
Qlife Holding AB (publ), a med-tech company, manufactures and sells in-vitro diagnostic analyzers and reagents. The company offers Egoo.Health Platform, an integrated platform with a measuring instrument with disposable capsules and software, where each capsule contains a test for a specific biomarker or virus. Its biomarkers include C-reactive protein home-testing capsule, PHE/Phenylalanine for PKU patients, and Sars-CoV-2/Influenza multiplex for virus/bacteria tests. The company was incorporated in 2019 and is based in Helsingborg, Sweden.
Qlife Holding AB (publ)’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.